SARA Pharm is the contract lab of choice for solid form screening & crystallization studies. Founded in 2011, we provide services worldwide having clients (till now) on all continents except Antarctica and South America. In our studies we use a large number of experiments of various types plus many crystallization conditions to find as many crystalline forms as possible, for IP protection and also to determine the most suitable solid form for further development. At the end of each study we scale-up to grams scale and determine the easiest and most cost-efficient method for producing the desired solid, to be further refined for production. We can perform pre-formulation studies that increase the chances in obtaining a strong understanding of the API properties such as solubility, stability and its compatibility with excipients. We are authorized to work with controlled substances too (narcotic drugs and psychotropic substances).
Looking for a particular SARA Pharm Solutions employee's phone or email?
The SARA Pharm Solutions annual revenue was $6.7 million in 2026.
Eugenia Mihalcea is the CEO of SARA Pharm Solutions.
2 people are employed at SARA Pharm Solutions.
The NAICS codes for SARA Pharm Solutions are [32, 325, 3254, 32541].
The SIC codes for SARA Pharm Solutions are [283, 28].